Business

Grant of Options

Grant of Options.

articleOptibiotix Health PlcJune 2, 20204/company/optibiotix-health-plc/news/grant-of-options-109
Grant of Options

About this update from Optibiotix Health Plc

[{"type":"text","content":"\n \n \n RNS Number : 7217O\n OptiBiotix Health PLC\n 02 June 2020\n  \n \n \n OPTIBIOTIX HEALTH PLC\n (the \"Company\" or \"OptiBiotix\")\n Grant of Options\n  \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces the grant of options, in aggregate, over 300,000 shares to employees of the Company.  The options were granted on 1 June 2020 at an exercise price of 57p.\n  \n The options have performance criteria attached to them which includes revenue and profitability targets. Option holders can only exercise their options and convert to shares once the performance criteria have been met. This ensures a continued focus on commercial revenues and shareholder value creation.\n \n  \n \n \n This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.\n \n \n  \n \n \n \n Stephen O'Hara, CEO of OptiBiotix, commented: \n \n \"The ability to attract and retain key staff who deliver to revenue and profitability targets and build shareholder value is important to OptiBiotix's continued success.  Granting share options helps OptiBiotix compete with remuneration packages offered by larger companies and incentivises the team to focus\n \n both effort and activity on rapidly growing revenues, reaching profitability, and building shareholder value. These options are offered to key staff and do not become exercisable until they achieve significant revenue targets which, if achieved, will create substantive shareholder value\".\n \n  \n \n For further information, please contact:\n \n \n  \n \n \n \n \n \n OptiBiotix Health plc\n \n \n \n \n \n www.optibiotix.com\n \n \n \n \n \n \n \n Stephen O'Hara, Chief Executive\n \n \n \n \n Contact via Walbrook below\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cairn Financial Advisers LLP (NOMAD)\n \n \n \n \n Tel: 020 7213 0880\n \n \n \n \n \n \n Liam Murray / Jo Turner / Ludovico Lazzaretti\n \n \n \n \n \n \n \n \n \n \n \n \n \n  \n \n \n finnCap (Broker)\n \n \n \n \n  \n \n \n Tel: 020 7220 0500\n \n \n \n \n \n \n Geoff Nash/ Scott Mathieson / Kate Bannatyne (Corporate Finance)\n \n \n \n \n \n \n \n \n \n \n \n \n \n Camille Gochez (Corporate Broki...

More updates from Optibiotix Health Plc